Longboat

01/06/2021

Patient advocacy groups are a powerful force in drug development. Check out our latest blog.

This blog outlines the origins and rise of patient advocacy groups, discussing the milestones in the FDA's acceptance of these groups.

26/04/2021

As study teams work to increase protocol compliance, participant retention, and future recruitment, focusing on creating a positive experience during the trial can reap many benefits. Check out or latest blog:

A positive participant experience underpins the success of any clinical trial. Leverage these key strategies to ensure success.

07/04/2021

News stories in the past year were dominated by COVID-19 vaccine development. While those involved in the clinical research industry understand the nuances to a clinical trial, too few of the general public truly understand the intricacies of vaccine development to see the bigger picture.

News stories in the past year were dominated by COVID-19 vaccine development. Everyone’s interested in the story, but how many know the ins and outs of vaccine development and how that affects research?

23/03/2021

In order to achieve patient centricity, clinical trials need to be site-centric first. With this mindset, what does it mean to be site-centric, and how does that improve the overall participation experience? Check out our latest blog.

What does it mean to be “site-centric” as a step toward patient centricity? Patient centricity has long been a key goal in healthcare, as well as in clinical research.

08/03/2021

Check out this excerpt from our eBook ‘How to Improve Site Compliance’.

A centralized repository for hosting this information, with version control management and the ability to generate customized reports, can facilitate this aspect of inspection preparation.

22/02/2021

Ahead of Rare Disease Day, we are taking a look at the Orphan Drug Act, which has helped to bring drugs and biologics to market in the fight against rare diseases.

Ahead of Rare Disease Day, we are taking a look at the Orphan Drug Act, which has helped to bring drugs and biologics to market in the fight against rare diseases.

15/02/2021

FDA annually reports the top most commonly cited violations in through their BIMO program. Let’s take a look at some of the most common.

The FDA inspects clinical trial sites and produces warning letters for violations found. FDA annually reports the top most commonly cited violations in clinical trials through their BIMO program. Let’s take a look at some of the most common.

02/02/2021

In a recent blog post, we talked about the diversity issue in clinical trials and the negative impact it has on research. Now, let’s address some practical ways pharma companies can apply to improve clinical trial diversity.

Let’s address some practical ways pharma companies can apply to improve clinical trial diversity.

18/01/2021

Check out this excerpt from our eBook 'The Power of Getting Everyone in Your Clinical Trial to Work as One Team'. https://hubs.ly/H0DZPyV0

Technology can lessen the burden on on-site staff, enabling them to maximize the limited face-to-face time they have with their patients.

04/01/2021

Successful teamwork involves much more than healthcare professionals complying with the protocol or study managers running and monitoring the trial. Check out this excerpt from our eBook.

Successful teamwork involves much more than healthcare professionals complying with the protocol or study managers running and monitoring the trial.

21/12/2020

Happy holidays to you and yours from all the team at Longboat by Advarra!

15/12/2020

As the pharma industry worked to identify and create a safe and effective COVID-19 vaccine at warp speed, this urgency highlighted one of the greatest challenges affecting modern pharmaceutical research, a lack of diversity in clinical trials.

Companies with ongoing COVID-19 investigational therapies and vaccines trials have placed a heavy emphasis on diversity, bringing the industry-wide issue to the global stage.